Skip to content

Foxy, a designer tryptamine hallucinogen.

Robert Meatherall, Pankaj Sharma

Journal of analytical toxicology January 1, 2003 DOI: 10.1093/jat/27.5.313 via PubMed

Summary

AI-generated from the abstract

A 21-year-old man ingested a pill called Foxy, containing the hallucinogen 5-methoxy-N,N-diisopropyltryptamine. In the hospital he experienced mild hallucinations and could not move his limbs for about two hours. A urine sample collected four hours after ingestion showed the drug at 1.7 micrograms per milliliter and its metabolite 5-methoxy-indole acetic acid at 1.3 micrograms per milliliter, identified by gas chromatography-mass spectrometry. Two other compounds, tentatively identified as 5-methoxy-N-isopropyltryptamine and 5-methoxy-N,N-diisopropyltryptamine-N'-oxide, were also found. The patient was discharged without follow-up.

Study at a glance

Characteristics Case report Peer reviewed
Sample size 1
Population 21-year-old Caucasian man who ingested Foxy
Duration 2 hours observation, no follow-up
Citations 77
Key finding The hallucinogen 5-methoxy-N,N-diisopropyltryptamine and its metabolites were identified and quantified in the patient's urine after ingestion of a pill called Foxy.

Abstract

Foxy is slang for 5-methoxy-N,N-diisopropyltryptamine. It has hallucinogenic properties, similar to other tryptamine compounds, and is mildly euphoric. This case report describes a 21-year-old Caucasian man who ingested a pill called Foxy containing an unknown amount of drug. He was observed in hospital for 2 h, during which time he had mild hallucinations and could not move his limbs. A urine sample was collected approximately 4 h after drug ingestion. The patient was then discharged with no follow up assessment. The 5-methoxy-N,N-diisopropyltryptamine was identified in the urine by gas chromatography-mass spectrometry. Standards prepared from the pure material were used in the identification. Quantitative analysis using the same analytical technique resulted in a urinary concentration of 1.7 micro g/mL. Through oxidative deamination, the metabolite, 5-methoxy-indole acetic acid, was formed. It was identified in the urine, and the concentration was determined to be 1.3 micro g/mL using gas chromatography-mass spectrometry. Two other compounds were discovered in the urine sample as a result of a routine drug screen. From their mass spectra, they were tentatively identified as 5-methoxy-N-isopropyltryptamine and 5-methoxy-N,N-diisopropyltryptamine-N'-oxide.

Comments

No comments yet.

Log in to comment